Under the 2020 health plan, Walmart employees get an incredible network of high-quality healthcare professionals. Ask your boss if this type of investment in employee...

Powerful A1C-lowering from Victoza now an option for ages 10-17, in addition to metformin and insulin

The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...

A bipartisan legislation, which would have protected patients from surprise medical bills, is blocked from passing this year

Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...

Maria shares her experiences and strategies for managing blood sugar levels while studying abroad

Low-cost monthly subscription services from mySugr, One Drop, DarioHealth, and Livongo

As we demand more nutritious and sustainable food, big food companies must make adjustments to their products, practices, and marketing

A trial is enrolling over 3,000 individuals living with type 2 diabetes and chronic kidney disease

Control-IQ the first AID system with automatic correction boluses and no fingersticks CGM (Dexcom G6); cleared for those ages 14 and older; launch in January 2020

The new BioSense ketone breath meter offers unlimited, effortless ketone measurements – just blow into the device

Adam’s presentation at Friends for Life 2019

A new pill combines Jardiance, Tradjenta, and metformin to help people with type 2 diabetes manage blood glucose levels more easily, and in many different ways

SGLT-2 inhibitors and GLP-1 agonists recommended as first-line therapies; Farxiga offers heart health benefits in people with and without diabetes

A new paper suggests that as people with diabetes increase their time in range, healthcare costs decrease

Nine industry leaders share insights on better diabetes outcomes at lower costs – The diaTribe Foundation’s 4 th annual Musings Under the Moon

Ozempic, a once weekly injectable GLP-1 agonist drug, is now approved to reduce the risk of heart attack and stroke. Rybelsus (a pill version of Ozempic) is confirmed to...

A new study shows that physical activity can add years to your life. Is this enough to motivate behavior change?

The first of its kind, Why WAIT is a creative app-based approach to weight loss and diabetes management

Regular eye screenings are important for people with diabetes. Learn more about diabetes-related retinopathy screenings from diabetes advocates Renza and Grumpy